IMCD México Integrates Millikan and Banner Química

IMCD entered the México market through the acquisition of DCS Pharma in 2019, followed by its rebranding to IMCD México in April 2020.
IMCD entered the México market through the acquisition of DCS Pharma in 2019, followed by its rebranding to IMCD México in April 2020.

IMCD México S.A. de C.V., part of IMCD Group, has announced that following the acquisition of Millikan and Banner Química in December 2020, the two companies have been fully integrated into the organization.

Related: IMCD Appoints Business Group Director Personal Care

Upon the integration of Millikan and Banner Química, IMCD México now comprises 80 employees and three laboratories to complement and support its commercial and technical activities.

Miguel Ruiseñor, managing director, IMCD México, said, “In only 15 months since IMCD México was officially established, not only have we grown organically, but we were able to fully integrate three companies into one IMCD organization. We have high ambitions for continued growth within this key LATAM market. Embarking on this new adventure as one team, this integration strengthens our operations and upholds our commitment to progressing the development of all our core markets in México to create a world of opportunities for our supplier partners and customers alike.”

More in News